Latest Europe News

Page 28 of 122
Eminence Minerals has appointed Anthony Hills as CEO, bringing over 16 years of global operational expertise to accelerate its exploration and project development efforts.
Maxwell Dee
Maxwell Dee
19 Jan 2026
Banco Santander has launched A$550 million of fixed rate senior notes due in 2031, exclusively aimed at professional and eligible counterparties under MiFID II regulations. The notes will be listed on the ASX and carry investment-grade ratings.
Victor Sage
Victor Sage
16 Jan 2026
Banco Santander has launched a A$450 million tranche of floating rate senior notes due in 2031, targeting exclusively professional and eligible counterparties under MiFID II regulations. The notes offer a quarterly interest rate tied to the 3-month BBSW plus a margin of 0.97%.
Claire Turing
Claire Turing
16 Jan 2026
Proteomics International has been granted a Canadian patent for its PromarkerEso blood test, a pioneering diagnostic tool for early detection of esophageal adenocarcinoma. This milestone strengthens its global intellectual property portfolio and paves the way for commercial expansion in North America.
Ada Torres
Ada Torres
16 Jan 2026
Critical Metals Corp reports robust 2025 drilling results at the Tanbreez Rare Earths Project, confirming consistent high-grade rare earth mineralisation with strategic metals. These findings underpin plans for resource growth and mine development.
Maxwell Dee
Maxwell Dee
15 Jan 2026
Neuren Pharmaceuticals’ partner Acadia projects DAYBUE sales to reach around US$700 million by 2028, driven by US market expansion and international approvals. The launch of a new formulation and ongoing clinical trials in Japan underpin this optimistic outlook.
Ada Torres
Ada Torres
14 Jan 2026
Little Green Pharma Ltd has agreed to acquire Cannatrek Ltd in a transformational merger that will create a leading vertically integrated medicinal cannabis group across Australia and Europe. The deal combines cultivation, manufacturing, distribution, clinics, and digital health platforms under one roof, positioning the combined entity for accelerated growth.
Ada Torres
Ada Torres
14 Jan 2026
Argent BioPharma has signed a binding agreement to acquire AusCann’s 48% stake in CannPal, enhancing its clinical and intellectual property assets for CannEpil®. The deal includes an option for the Neuvis® drug-delivery platform and aligns with Argent’s U.S. dual-listing ambitions.
Ada Torres
Ada Torres
14 Jan 2026
Proteomics International Laboratories has appointed David Morris as CEO and Managing Director, marking a strategic shift towards commercialising its Promarker® diagnostic technology. Morris brings extensive global healthcare leadership experience to lead the company’s next growth phase.
Ada Torres
Ada Torres
14 Jan 2026
ECS Botanics reports a $218k positive operating cash flow in Q2 FY26, driven by strong B2C growth and new product launches. The company also secured $1.95 million in funding to fuel European expansion and product development.
Ada Torres
Ada Torres
14 Jan 2026
Osmond Resources is fast-tracking development of its Orión EU Critical Minerals Project, with initial drilling confirming high-grade titanium, zircon, and rare earth elements. The company aims to complete a maiden Mineral Resource Estimate and Scoping Study by mid-2026.
Maxwell Dee
Maxwell Dee
13 Jan 2026
Vection Technologies has secured a $0.5 million follow-on purchase order from KIOSK Embedded Systems, expanding its AI kiosk portfolio and reinforcing its recurring revenue streams in Central Europe’s hospitality sector.
Sophie Babbage
Sophie Babbage
13 Jan 2026